Relugolix combo treatment may reduce opioid use in endometriosis-related discomfort Jacinthlyn Sylvia20 Sept 2022 8:00 PM ISTUSA: Relugolix combo treatment taken once a day reduced endometriosis-related discomfort and was well tolerated by patients, says an article published...
Pfizer, Myovant Sciences get USFDA nod for MYFEMBREE Ruchika Sharma7 Aug 2022 11:30 AM ISTMYFEMBREE offers an effective, once-daily treatment option for the management of moderate to severe pain associated with endometriosis, with a...
Myovant Sciences, Accord Healthcare ink pact for prostate cancer treatment Relugolix Ruchika Sharma10 May 2022 10:15 AM ISTORGOVYX (relugolix, 120 mg) is indicated in Europe for the treatment of adult patients with advanced hormone-sensitive prostate cancer.
Relugolix combo significantly reduces menstrual bleeding in uterine fibroids patients: NEJM Medha Baranwal18 Feb 2021 7:01 PM ISTUSA: Once-daily treatment with relugolix combination therapy (relugolix, estradiol and norethindrone acetate) significantly reduces menstrual bleeding...
FDA Approves first Oral Hormone Therapy for Treating Advanced Prostate Cancer Hina Zahid20 Dec 2020 8:43 PM ISTThe FDA has approved relugolix an oral androgen deprivation therapy ADT for men with advanced prostate cancer. The FDA granted approval of Orgovyx to...
Prostate cancer: Oral relugolix bests inj leuprolide for rapid testosterone suppression Medha Baranwal1 July 2020 1:30 PM ISTUSA: The use of oral relugolix in men with prostate cancer may help to achieve rapid, sustained suppression of testosterone levels as compared...
